Trademark: 79168375
Word
LYOPAN
Status
Dead
Status Code
709
Status Date
Friday, July 8, 2022
Serial Number
79168375
Registration Number
4872521
Registration Date
Tuesday, December 22, 2015
Mark Type
4000
Filing Date
Wednesday, January 14, 2015
Published for Opposition
Tuesday, October 6, 2015
Cancellation Date
Friday, July 8, 2022

Trademark Owner History
Pantec AG - Original Registrant

Classifications
5 Almond oils for pharmaceutical purposes; Antibacterial pharmaceuticals; Anti-diabetic pharmaceuticals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Delivery agents in the form of dissolvable films and coatings for tablets that facilitate the delivery of nutritional supplements and of pharmaceutical preparations; Homeopathic pharmaceuticals for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical antitussive-cold preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for skin care; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for the treatment of joint disease; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Pharmaceuticals, namely, anti-infectives; Amino acids for medical or veterinary purposes; Anti-infective products for veterinary use; Bacterial and bacteriological preparations for medical or veterinary purposes; Bacteriostats for medicinal, dental and veterinary use; Biochemical preparations, namely, reagents for medical and veterinary diagnostic purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Veterinary preparations, namely, pain relief medication; Veterinary preparations for treatment of intestinal bacteria; Veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders in a variety of animal; Veterinary preparations, namely, antioxidants; veterinary vaccines; health care preparations, namely, dietary supplements; Dietetic foods adapted for medical use, namely, bread, cookies and crackers; Diet capsules, Diet pills, Food for medically restricted diets, namely, pasta, crackers and candy adapted for medical use; food for babies; medical plasters; medical dressings; material for dental fillings and dental impressions; all-purpose disinfectants; Gastrointestinal cleaning agents; sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, dietetic candy; preparations for destroying vermin; fungicides; herbicides; nutritional supplements; pharmaceutical effervescent tablets for treating upset stomach and stomach disease; medicine delivery agents in the form of soft-gelatin capsules for the controlled release of active ingredients for a wide range of pharmaceutical products; medicine delivery agents in the form of powders for the controlled release of active ingredients for a wide range of pharmaceutical products; medicine delivery agents in the form of tablets for the controlled release of active ingredients for a wide range of pharmaceutical products
3 Dental bleaching gels, Tooth bleaching preparations, Laundry bleach, blueing, detergent, pre-soak, sizing, soap and starch; general purpose cleaning, polishing, degreasing and abrasive liquids and powders; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices; descaling agents and descaling agents in tablet form for household use; all-purpose cleaning preparations
1 Chemicals for use in industry and science; photographic chemicals; chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins, unprocessed plastics; soil fertilizers; fire extinguishing compositions; tempering preparations; soldering chemicals; tempering chemicals for use in soldering; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leather; adhesives for use in industry; descaling preparations and descaling preparations in tablet form for industrial purposes
The wording "LYOPAN" has no meaning in a foreign language.

Trademark Events
May 9, 2023
Total Invalidation Processed By The Ib
Apr 20, 2023
Total Invalidation Of Reg Ext Protection Sent To Ib
Apr 20, 2023
Invalidation Processed
Mar 8, 2023
Total Invalidation Of Reg Ext Protection Created
Jul 8, 2022
Cancelled Section 71
Dec 22, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 15, 2016
Final Decision Transaction Processed By Ib
Apr 11, 2016
Final Disposition Notice Sent To Ib
Apr 11, 2016
Final Disposition Processed
Mar 22, 2016
Final Disposition Notice Created, To Be Sent To Ib
Feb 22, 2016
Correction From The Ib Examined, No Action Is Needed
Feb 12, 2016
Correction Transaction Received From Ib
Dec 22, 2015
Registered-Principal Register
Oct 6, 2015
Official Gazette Publication Confirmation E-Mailed
Oct 6, 2015
Published For Opposition
Oct 2, 2015
Notification Processed By Ib
Sep 16, 2015
Notification Of Possible Opposition Sent To Ib
Sep 16, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 16, 2015
Notification Of Notice Of Publication E-Mailed
Sep 1, 2015
Law Office Publication Review Completed
Aug 28, 2015
Approved For Pub - Principal Register
Aug 28, 2015
Teas/Email Correspondence Entered
Aug 28, 2015
Correspondence Received In Law Office
Aug 28, 2015
Teas Request For Reconsideration Received
Aug 27, 2015
Notification For Req For Recon Denied No Appeal Filed
Aug 27, 2015
Action For Req For Recon Denied No Appeal Filed E-Mailed
Aug 27, 2015
Action Req For Recon Denied No Appeal Filed Counted Not Mailed
Aug 27, 2015
Teas/Email Correspondence Entered
Aug 26, 2015
Correspondence Received In Law Office
Aug 26, 2015
Teas Request For Reconsideration Received
Aug 5, 2015
Notification Of Final Refusal Emailed
Aug 5, 2015
Final Refusal E-Mailed
Aug 5, 2015
Final Refusal Written
Aug 5, 2015
Teas/Email Correspondence Entered
Aug 5, 2015
Correspondence Received In Law Office
Aug 1, 2015
Refusal Processed By Ib
Jul 28, 2015
Assigned To Lie
Jul 19, 2015
Teas Response To Office Action Received
Jul 14, 2015
Application Filing Receipt Mailed
Jul 13, 2015
Non-Final Action Mailed - Refusal Sent To Ib
Jul 13, 2015
Refusal Processed By Mpu
Jul 12, 2015
Non-Final Action (Ib Refusal) Prepared For Review
Jul 11, 2015
Non-Final Action Written
Jul 10, 2015
Assigned To Examiner
Jul 10, 2015
New Application Office Supplied Data Entered
Jul 9, 2015
Sn Assigned For Sect 66a Appl From Ib

B
W
Trademark Alertz updated from USPTO on 2030-01-24